TipRanks
Royalty Pharma PLC (DE:RPD)
XETRA:RPD

Compare Royalty Pharma (RPD) vs. Competitors

6 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Royalty Pharma
€53.61
€28.85B
23.61
62.05%
7 Buy
0 Hold
0 Sell
Strong Buy
Corcept Therapeutics
$123.57
$12.81B
233.70
34.05%
4 Buy
0 Hold
1 Sell
Moderate Buy
Prestige Consumer Healthcare
$51.21
$2.27B
13.51
-24.36%
2 Buy
0 Hold
0 Sell
Moderate Buy
Sinovac Biotech
$6.47
$460.27M
-7.80
0.00%
―
Kiniksa Pharmaceuticals
$80.20
$6.14B
74.33
105.56%
7 Buy
0 Hold
0 Sell
Strong Buy
Liquidia Technologies
$70.49
$2.51B
17.61
16.36%
4 Buy
4 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:RPD
Royalty Pharma
49.48
19.24
63.65%
CORT
Corcept Therapeutics
118.54
44.58
60.28%
PBH
Prestige Consumer Healthcare
47.87
-13.13
-21.52%
SVA
Sinovac Biotech
6.47
0.00
0.00%
KNSA
Kiniksa Pharmaceuticals
78.75
40.86
107.84%
LQDA
Liquidia Technologies
28.02
4.83
20.83%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts